BA MA - Akanda Corp Chief Officer
| AKAN Stock | USD 1.34 0.03 2.19% |
Executive
BA MA is Chief Officer of Akanda Corp
| Age | 74 |
| Address | 1a, 1b Learoyd Road, New Romney, United Kingdom, TN28 8XU |
| Phone | 44 20 2498 7917 |
| Web | https://www.akandacorp.com |
Akanda Corp Management Efficiency
The company has return on total asset (ROA) of (0.2552) % which means that it has lost $0.2552 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.4288) %, meaning that it created substantial loss on money invested by shareholders. Akanda Corp's management efficiency ratios could be used to measure how well Akanda Corp manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Akanda Corp's Return On Capital Employed is very stable compared to the past year. As of the 21st of November 2024, Return On Equity is likely to grow to 8.85, though Return On Tangible Assets are likely to grow to (6.08). At this time, Akanda Corp's Intangible Assets are very stable compared to the past year. As of the 21st of November 2024, Debt To Assets is likely to grow to 0.79, while Other Assets are likely to drop about 386.9 K.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jaclyn Jaffe | Journey Medical Corp | N/A | |
| Steve Laninga | Lifecore Biomedical | N/A | |
| Jerome Dvonch | Sonoma Pharmaceuticals | 56 | |
| Joseph Benesch | Journey Medical Corp | 57 | |
| Jackie Klecker | Lifecore Biomedical | N/A | |
| Brikkelle Thompson | Lifecore Biomedical | N/A | |
| Timothy CPA | Shuttle Pharmaceuticals | 66 | |
| Gene Esq | Shuttle Pharmaceuticals | N/A | |
| Samantha Widdicombe | Biofrontera | N/A | |
| John Poggetto | Sonoma Pharmaceuticals | 52 | |
| Huang CFA | China Pharma Holdings | N/A | |
| Jon MBA | Biofrontera | N/A | |
| Daniel JD | Biofrontera | N/A | |
| Matt Augustson | Lifecore Biomedical | N/A | |
| Andrew Zwible | Journey Medical Corp | N/A | |
| Kara Morley | Lifecore Biomedical | N/A | |
| John Shulman | Petros Pharmaceuticals | 61 | |
| Alycia Torres | Biofrontera | N/A | |
| Ramsey Alloush | Journey Medical Corp | 38 | |
| Darren Hieber | Lifecore Biomedical | N/A | |
Management Performance
| Return On Equity | -2.43 | ||||
| Return On Asset | -0.26 |
Akanda Corp Leadership Team
Elected by the shareholders, the Akanda Corp's board of directors comprises two types of representatives: Akanda Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Akanda. The board's role is to monitor Akanda Corp's management team and ensure that shareholders' interests are well served. Akanda Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Akanda Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Flow, Chief Officer | ||
| BComm BCom, Ex Chairman | ||
| Tejinder Virk, CEO Director | ||
| BA MA, Chief Officer | ||
| BCom BAcc, CFO Sec | ||
| Katharyn Field, Interim Director |
Akanda Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Akanda Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.43 | ||||
| Return On Asset | -0.26 | ||||
| Operating Margin | (4.93) % | ||||
| Current Valuation | (3.68 M) | ||||
| Shares Outstanding | 1.43 M | ||||
| Shares Owned By Insiders | 1.65 % | ||||
| Shares Owned By Institutions | 0.45 % | ||||
| Number Of Shares Shorted | 104.18 K | ||||
| Price To Book | 0.43 X | ||||
| Price To Sales | 0.78 X |
Pair Trading with Akanda Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Akanda Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akanda Corp will appreciate offsetting losses from the drop in the long position's value.Moving together with Akanda Stock
Moving against Akanda Stock
| 0.9 | AMLX | Amylyx Pharmaceuticals | PairCorr |
| 0.86 | PRAX | Praxis Precision Med | PairCorr |
| 0.77 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.76 | AKRO | Akero Therapeutics | PairCorr |
| 0.63 | CRNX | Crinetics Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to Akanda Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Akanda Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Akanda Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Akanda Corp to buy it.
The correlation of Akanda Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Akanda Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Akanda Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Akanda Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akanda Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Akanda Stock, please use our How to Invest in Akanda Corp guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akanda Corp. If investors know Akanda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akanda Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (524.76) | Revenue Per Share 9.388 | Quarterly Revenue Growth 2.705 | Return On Assets (0.26) | Return On Equity (2.43) |
The market value of Akanda Corp is measured differently than its book value, which is the value of Akanda that is recorded on the company's balance sheet. Investors also form their own opinion of Akanda Corp's value that differs from its market value or its book value, called intrinsic value, which is Akanda Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akanda Corp's market value can be influenced by many factors that don't directly affect Akanda Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akanda Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akanda Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akanda Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.